An injectable blood pressure drug has been recalled after the FDA has warned it could cause side effects, such as stroke or death.

Provepharm said it pulled lot No. 24020027 with December 2025 of Phenylephrine hydrochloride Injection, USP, 10 mg/mL after ...

Doctors say that for many patients, these medications help them get control of their obesity and other weight-related medical ...

Fact checked by Nick Blackmer The recent approvals of Leqembi (lecanemab) and Kisunla (donanemab) have refreshed the ...

President Donald Trump has signed a sweeping execution order on the death penalty that directs the attorney general to “take ...

Provepharm is recalling lot number 24020027; Expiry Date December 2025 of Phenylephrine hydrochloride Injection, USP, 10 mg/ ...

All three have chosen lethal injection over the electric chair or a firing squad, which was created when the state feared it ...

Novo’s shares were up more than 10% this morning. The injectable drug targets the GLP-1 and amylin hormones. Novo is also developing amycretin as a pill and reported positive results from an ...

A press freedom group representing the Indiana Capital Chronicle has filed a lawsuit in Marion Superior Court against the Indiana Department of Correction, alleging that the state agency violated ...

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...